TOLAK Drug Patent Profile
✉ Email this page to a colleague
When do Tolak patents expire, and when can generic versions of Tolak launch?
Tolak is a drug marketed by Hill Dermaceuticals and is included in one NDA.
The generic ingredient in TOLAK is fluorouracil. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tolak
A generic version of TOLAK was approved as fluorouracil by FRESENIUS KABI USA on September 30th, 1998.
Summary for TOLAK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 216 |
| Patent Applications: | 193 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TOLAK |
| What excipients (inactive ingredients) are in TOLAK? | TOLAK excipients list |
| DailyMed Link: | TOLAK at DailyMed |
Pharmacology for TOLAK
| Drug Class | Nucleoside Metabolic Inhibitor |
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for TOLAK
US Patents and Regulatory Information for TOLAK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hill Dermaceuticals | TOLAK | fluorouracil | CREAM;TOPICAL | 022259-001 | Sep 18, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TOLAK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hill Dermaceuticals | TOLAK | fluorouracil | CREAM;TOPICAL | 022259-001 | Sep 18, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TOLAK
See the table below for patents covering TOLAK around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 2541373 | COMPOSITION TOPIQUE DE SOINS DE LA PEAU CONTENANT DE L'HUILEDE CACAHUETES RAFFINEE (TOPICAL SKIN CARE COMPOSITION CONTAINING REFINED PEANUT OIL) | ⤷ Try a Trial |
| European Patent Office | 1696868 | COMPOSITION TOPIQUE DE SOINS DE LA PEAU CONTENANT DE L'HUILE DE CACAHUETES RAFFINEE (TOPICAL SKIN CARE COMPOSITION CONTAINING REFINED PEANUT OIL) | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2005009406 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
